Krystal Biotech buy Guggenheim
Start price
07.05.25
/
50%
€120.90
Target price
07.05.26
€166.60
Performance (%)
99.01%
Price
18.02.26
€240.60
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Krystal Biotech has seen massive gains of 99.01%. This prediction currently runs until 07.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 4.791% | 4.791% |
| iShares Core DAX® | 1,07 % | -0,52 % |
| iShares Nasdaq 100 | -0,49 % | -4,06 % |
| iShares Nikkei 225® | -2,03 % | 6,91 % |
| iShares S&P 500 | -0,10 % | -2,37 % |
Comments by Guggenheim for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target lowered by analysts at Guggenheim from $195.00 to $189.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Guggenheim for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€161.18
27.02.25
27.02.25
14.14%
28.02.25
28.02.25
